Actual Medicinal Product (AMP) Raponer XL 2mg tablets (Accord-UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Raponer XL tablets (Accord Healthcare Ltd).

Generic
Ropinirole
Formulation
Ropinirole 2mg modified-release tablets
  • Ropinirole
    • Ropinirole 2mg modified-release tablets

      • Raponer XL 2mg tablets (Accord-UK Ltd)

Alternative Suppliers (18)

compatible logo ReQuip XL 2mg tablets (GlaxoSmithKline UK Ltd)
compatible logo ReQuip XL 2mg tablets (Sigma Pharmaceuticals Plc)
compatible logo ReQuip XL 2mg tablets (DE Pharmaceuticals)
compatible logo Ralnea XL 2mg tablets (Krka UK Ltd)
compatible logo Repinex XL 2mg tablets (Aspire Pharma Ltd)
compatible logo Raponer XL 2mg tablets (Accord Healthcare Ltd)
compatible logo Ipinnia XL 2mg tablets (Ethypharm UK Ltd)
compatible logo Ropiqual XL 2mg tablets (Milpharm Ltd)
compatible logo Ropinirole 2mg modified-release tablets (Krka UK Ltd)
compatible logo ReQuip XL 2mg tablets (Waymade Healthcare Plc)
compatible logo ReQuip XL 2mg tablets (Mawdsley-Brooks & Company Ltd)
compatible logo ReQuip XL 2mg tablets (Necessity Supplies Ltd)
compatible logo Spiroco XL 2mg tablets (Teva UK Ltd)
compatible logo Raponer XL 2mg tablets (Accord-UK Ltd)
compatible logo Aimpart XL 2mg tablets (Zentiva Pharma UK Ltd)
compatible logo Ropinirole 2mg modified-release tablets (Colorama Pharmaceuticals Ltd)
compatible logo Ropilynz XL 2mg tablets (Lupin Healthcare (UK) Ltd)
compatible logo Ropinirole 2mg modified-release tablets (Viatris UK Healthcare Ltd)